Abraaj’s Cleopatra announces indicative price range on offering; company in London today for first leg of roadshow: Egypt’s second public offering of the year has been priced at EGP 8.75-11.88 per share, according to a price range announcement (pdf) released this morning by Cleopatra Hospital Company, Egypt’s largest private-sector hospital group. That range values the offering of 40 mn shares at EGP 350 mn to EGP 475 mm. EFG Hermes has the company in London this morning for the first leg of the roadshow. The offering will “raise capital to support expansion and growth” and includes up to 34 mn shares for international investors and 6 mn in an Egyptian retail offer. Selling shareholders will re-inject the net proceeds of the transaction into Cleopatra to fuel growth by subscribing to a rights issue for the same number of shares as are sold in the secondary sale. The company’s shares are likely to begin trading in the first week of June. Our previous coverage of the transaction, including a downloadable copy of the company’s intention to float, is here, or you can tap here for a link to the company’s website for the transaction. EFG Hermes is sole global coordinator and bookrunner for the offering; Pharos Holding is manager. Freshfields Bruckhaus Deringer LLP is international counsel to Cleopatra Hospital Company, while Zulficar & Partners are local counsel. Shearman & Sterling (London) LLP is international counsel to the sole global coordinator and bookrunner, while Matouk Bassiouny is local counsel.